| Authors: |
Gordon MJ; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Miljkovic MD; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.; Cartesian Therapeutics, Gaithersburg, MD., Milhon P; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Lakhotia R; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Melani C; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Johnson K; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Bryant B; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Pittaluga S; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Jaffe ES; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Conlon K; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Staudt LM; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Wilson WH; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Roschewski M; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Ng S; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD. |
